← Back
Data updated: Mar 10, 2026
NORWICH
Pharmaceuticals
NORWICH is a pharmaceutical company with 3 FDA-approved products.
1993
Since
3
Drugs
-
Trials
13
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
LISDEXAMFETAMINE DIMESYLATE 2025-01-29
LISDEXAMFETAMINE DIMESYLATE 2025-01-23
Labeling
LISDEXAMFETAMINE DIMESYLATE 2024-12-26
Manufacturing (CMC)
LISDEXAMFETAMINE DIMESYLATE 2024-12-17
LISDEXAMFETAMINE DIMESYLATE 2024-12-16
LISDEXAMFETAMINE DIMESYLATE 2024-11-15
LISDEXAMFETAMINE DIMESYLATE 2024-10-25
Labeling
LISDEXAMFETAMINE DIMESYLATE 2024-09-25
Labeling
LISDEXAMFETAMINE DIMESYLATE 2024-09-25
Labeling
LISDEXAMFETAMINE DIMESYLATE 2024-09-16
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (1)
Company Info
- First Approval
- 1993-04-21
- Latest
- 2024-01-05
- Applications
- 3